ArticleOncology reports2022

Potential of VEGFR2 expression as a predictive marker of PD‑1 blockade in patients with advanced NSCLC.

Kyoichi Kaira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.